Roundhill Magnificent Seven ETF

MAGS

Based on the provided information, a complete introduction cannot be generated as the company's business, sector, and defining characteristics are listed as unavailable.
To proceed, please provide the necessary details about the company MAGS.

$61.15 +0.00 (+0.00%)

Updated: February 16, 2026, 16:00 EST

Analyzed by Rockflow Bobby Quantitative Model ✓ Updated Daily

Investment Opinion: Should I buy MAGS Today?

Based on the available information, a buy recommendation for MAGS carries significant uncertainty and is not advisable at this time.

The technical picture suggests the stock is oversold after a significant decline, which could appeal to contrarian investors. However, the high volatility and recent underperformance against the market indicate inherent risk and weak momentum. Crucially, the inability to perform a fundamental or valuation analysis due to missing financial data is a major red flag, preventing any assessment of the company's underlying health or fair value.

While the lack of short interest is a minor positive, the absence of essential financial disclosures makes an informed investment decision impossible. The combination of high volatility and a complete lack of fundamental transparency presents an unacceptable level of risk for most investors.

Recommendation: Do Not Buy. The inability to verify the company's financial viability or valuation makes this stock highly speculative. Investors should wait for comprehensive financial disclosures before considering any position. For reference only; this is not investment advice.

CTA Banner

MAGS 12-Month Price Forecast

RockFlow Model Forecast: Three Scenarios for 2026

Based on the comprehensive analysis provided, the 12-month outlook for MAGS is highly speculative and carries significant risk.

* Key Catalysts: The primary catalyst would be the company releasing comprehensive financial disclosures, which would allow for a fundamental analysis of its viability and fair value. A technical bounce from oversold conditions could also provide a short-term boost. * Potential Risks: The dominant risk is the complete lack of financial transparency, making it impossible to assess the company's health or value. This is compounded by high volatility and weak momentum, indicating substantial downside potential. * Target Price Range: No reliable target price can be established. In the absence of fundamental data, assigning a price target would be purely speculative. The recommendation is to avoid the stock until adequate financial information is available.

Wall Street Consensus

Most Wall Street analysts are optimistic about Roundhill Magnificent Seven ETF's 12-month outlook, with consensus target around $61.15, indicating expected upside potential.

Average Target
$61.15
0 analysts
Implied Upside
+0%
vs. current price
Analyst Count
0
covering this stock
Price Range
$49 - $80
Analyst target range
Buy Buy
0 (0%)
Hold Hold
0 (0%)
Sell Sell
0 (0%)

Bulls vs Bears: MAGS Investment Factors

Overall, MAGS has investment potential but also faces challenges. Here are key factors to weigh before investing.

Bullish Bullish
  • Strong ETF Performance: MAGS ETF is up 16.6% year-to-date despite recent headwinds.
  • Resilient Rally: Magnificent Seven stocks keep bouncing back with recent surges.
  • Institutional Interest: Berkshire Hathaway disclosed a new position in a Mag 7 stock.
  • AI Dominance Potential: Elon Musk sees certain Mag 7 stocks as extremely valuable in AI.
  • Market Leadership: The group represents high-performing, influential companies in the U.S. market.
Bearish Bearish
  • Recent Weakness: ETF is down about 7% in November due to multiple headwinds.
  • Underperformance Warning: Goldman Sachs expects Mag 7 to trail equal-weight S&P 500.
  • AI Spending Concerns: Underperformance may stem from high AI capital expenditures and crowded trades.
  • Analyst Pessimism: Some longtime bulls now advise underweighting the Mag 7 group.
  • Tesla Weakness: Key component Tesla stock remains below a critical level.
Reward Banner

MAGS Technical Analysis

MAGS has delivered mixed price performance with notable volatility, experiencing significant recent declines while maintaining substantial gains from yearly lows. The stock demonstrates higher-than-market volatility with a beta exceeding 1.3.

Over the past one and three months, MAGS has significantly underperformed the broader market, registering declines of 5.89% and 9.37% respectively. This underperformance is confirmed by the -9.42% relative strength figure against market benchmarks, indicating persistent weakness in the short term.

Currently trading at $61.15, MAGS sits approximately 71% above its 52-week low but remains 12% below its yearly high of $69.14. Given the recent sell-off and maximum drawdown of -26.72% over the past year, the stock appears oversold rather than overbought at current levels.

📊 Beta
1.33
1.33x market volatility
📉 Max Drawdown
-26.7%
Largest decline past year
📈 52-Week Range
$39-$69
Price range past year
💹 Annual Return
+10.9%
Cumulative gain past year
Period MAGS Return S&P 500
1m -5.9% -1.2%
3m -9.4% +0.1%
6m +3.7% +7.8%
1y +10.9% +11.5%
ytd -6.4% -0.2%

MAGS Fundamental Analysis

Based on the information provided, a fundamental analysis cannot be performed. The required financial data, including the recent quarterly report and key financial ratios, are unavailable.

Without access to revenue figures, profit margins, or cash flow statements, it is impossible to assess the company's financial health. An analysis of debt levels or operational efficiency is equally unfeasible.

The absence of disclosed financial information is a significant limitation. A professional assessment would require this essential data to evaluate MAGS's performance and stability.

Quarterly Revenue
N/A
Latest Quarter
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A%
Latest Quarter
Free Cash Flow
N/A
Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

RockFlow Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

Try Now & Get Tesla Stock Reward

Valuation Analysis: Is MAGS Overvalued?

Valuation analysis cannot be conducted for MAGS due to missing financial metrics. Without PE ratios or other valuation multiples, it is impossible to determine whether the stock is overvalued or undervalued based on traditional valuation frameworks.

Peer comparison cannot be performed as both company-specific valuation metrics and industry benchmark data are unavailable. This absence of comparative data prevents any meaningful assessment of MAGS's relative valuation position within its sector.

PE
N/Ax
TTM
vs. Historical
N/A
vs. Industry Avg
N/A
Industry PE ~N/A×
EV/EBITDA
N/Ax
Enterprise Value Multiple

Investment Risk Disclosure

Volatility Risk: MAGS exhibits elevated volatility risk with a beta of 1.33, indicating it is approximately 33% more volatile than the broader market. This heightened sensitivity is further confirmed by a significant 1-year maximum drawdown of -26.72%, suggesting the stock is prone to substantial declines during market stress. Investors should be prepared for pronounced price swings relative to the overall market.

Other Risks: A notable positive factor is the absence of short interest, which removes the risk of a short squeeze and reflects minimal speculative downward pressure from traders. However, the stock's overall liquidity profile remains a key consideration for risk assessment and could pose challenges for executing large orders without impacting the price.

FAQs

Is MAGS a good stock to buy?

Neutral/Bearish: MAGS appears speculative given its significant volatility and recent underperformance (-9% over 3 months), compounded by a complete lack of fundamental data for proper evaluation. While the ETF shows strong YTD AI-driven momentum, current headwinds and analyst skepticism suggest near-term pressure. Suitable only for aggressive traders comfortable with high-volatility swings and incomplete financial transparency.

Is MAGS stock overvalued or undervalued?

Based on the provided information, MAGS stock cannot be classified as overvalued or undervalued. This is because the fundamental data required for valuation—such as PE, PB, and PS ratios—is entirely unavailable, making any comparison to industry averages or historical levels impossible. The complete absence of financial metrics and statements prevents any meaningful assessment of the company's growth expectations or profitability, which are essential for determining valuation. A proper analysis would require access to this basic financial information.

What are the main risks of holding MAGS?

Based on the provided information, the key risks of holding MAGS are:

1. Market & Volatility Risk: The stock exhibits high volatility with a beta of 1.33, making it prone to sharper price swings and significant losses, as evidenced by its 1-year maximum drawdown of -26.72%. 2. Liquidity Risk: The stock's overall liquidity profile could pose challenges for investors seeking to execute large trades without adversely impacting the market price. 3. Financial Transparency Risk: The complete absence of available fundamental financial data, such as revenue, profitability, and debt levels, creates significant uncertainty regarding the company's underlying financial health and stability. 4. Recent Performance Risk: The stock has demonstrated persistent short-term weakness, significantly underperforming the broader market over the past one and three months, indicating a loss of momentum.

What is the price forecast for MAGS in 2026?

Based on the provided information, there is no reliable MAGS stock forecast for 2026.

* Target Price Range / Key Drivers: It is impossible to establish a target price or identify key growth drivers as the complete lack of financial disclosures prevents any fundamental analysis of the company's viability, health, or value. * Main Assumptions / Uncertainty: Any forecast would be based purely on speculation rather than data, and the extreme uncertainty is the defining characteristic, with the dominant risk being a complete failure due to non-transparency.

Until the company releases comprehensive financial statements, the only prudent recommendation is to avoid the stock entirely.